Multi-centre randomised controlled trial of a smart phone-based event recorder alongside standard care versus standard care for patients presenting to the Emergency Department with palpitations and pre-syncope - the IPED (Investigation of Palpitations in the ED) study: study protocol for a randomised controlled trial

Matthew J Reed, Neil R Grubb, Christopher C Lang, Rachel O'Brien, Kirsty Simpson, Mia Padarenga, Alison Grant, Sharon Tuck, Matthew J Reed, Neil R Grubb, Christopher C Lang, Rachel O'Brien, Kirsty Simpson, Mia Padarenga, Alison Grant, Sharon Tuck

Abstract

Background: Palpitations and pre-syncope are together responsible for 300,000 annual Emergency Department (ED) attendances in the United Kingdom (UK). Diagnosis of the underlying rhythm is difficult as many patients are fully recovered on ED arrival; and examination and presenting electrocardiogram (ECG) are commonly normal. The only way to establish the underlying heart rhythm is to capture an ECG during symptoms. Recent technology advances have led to several novel ECG monitoring devices appearing on the market. This trial aims to compare the symptomatic rhythm detection rate at 90 days of one such smart phone-based event recorder (AliveCor Heart Monitor and AliveECG) with standard care for participants presenting to the ED with palpitations and pre-syncope and no obvious cause in the ED.

Methods/design: This is a multi-centre hospital ED / Acute Medical Unit (AMU) open label, randomised controlled trial. Participants will be recruited in 10 tertiary and district general hospitals in the UK. Participants aged ≥ 16 years presenting with an episode of palpitations or pre-syncope with no obvious cause and whose underlying ECG rhythm during these episodes remains undiagnosed after clinical assessment will be included. Participants will be randomised to either: (1) the intervention arm, standard care plus the use of a smart phone-based event recorder; or (2) the control arm, standard care. Primary endpoint will be symptomatic rhythm detection rate at 90 days. A number of secondary clinical, process and cost-effectiveness endpoints will be collected and analysed. Analysis will be on an intention-to-treat basis.

Discussion: The Investigation of Palpitations in the ED (IPED) study aims to recruit 242 participants across 10 hospital sites. It will be the first study to investigate the ability of a smart phone-based event recorder to detect symptomatic cardiac rhythms compared to standard care for ED patients with palpitations and pre-syncope with no obvious cause in the ED. This smart phone event recorder will allow ED patients who have presented with palpitations or pre-syncope to record their ECG tracing if they have a further episode and may increase the rate of underlying rhythm diagnosis.

Trial registration: ClinicalTrials.gov, NCT02783898 . Registered on 26 May 2016.

Keywords: Ambulatory electrocardiography monitoring; Cardiac arrhythmias; Palpitations; Pre-syncope.

Conflict of interest statement

Ethics approval and consent to participate

A favourable ethical opinion was obtained from South East Scotland Research Ethics Committee 02 (REC reference: 16/SS/0074) on 5 May 2016 for the Edinburgh site and from HRA on 29 December 2016 for all other sites. Written consent was obtained from all participants.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Trial assessment schedule

References

    1. Thiruganasambandamoorthy V, Stiell IG, Wells GA, Vaidyanathan A, Mukarram M, Taljaard M. Outcomes in presyncope patients: a prospective cohort study. Ann Emerg Med. 2015;65(3):268–276. doi: 10.1016/j.annemergmed.2014.07.452.
    1. Probst MA, Mower WR, Kanzaria HK, Hoffman JR, Buch EF, Sun BC. Analysis of emergency department visits for palpitations (from the National Hospital Ambulatory Medical Care Survey) Am J Cardiol. 2014;113(10):1685–1690. doi: 10.1016/j.amjcard.2014.02.020.
    1. Dimarco AD, Onwordi EN, Murphy CF, Walters EJ, Willis L, Mullan NJ. . Brit J Cardio. 2018. .
    1. Blomstrom-Lundqvist C, Sheinman MM, Aliot EM, Alpert JS, Calkins H, Camm AJ, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias – executive summary. J Am Coll Cardiol. 2003;42:1493–1531.
    1. Raviele A, Giada F, Bergfeldt L, Blanc JJ, Blomstrom-Lundqvist C, Mont L, et al. Management of patients with palpitations: a position paper from the European Heart Rhythm Association. Europace. 2011;13:920–934. doi: 10.1093/europace/eur130.
    1. National Institute for Health and Care Excellence. NICE clinical knowledge summaries. Palpitations. London: NICE; 2015. (Accessed 16 Aug 2018).
    1. Zimetbaum PJ, Josephson ME. The evolving role of ambulatory arrhythmia monitoring in general practice. Ann Intern Med. 1999;150:848–856. doi: 10.7326/0003-4819-130-10-199905180-00020.
    1. Scherr D, Dalal D, Henrikson CA, Spragg DD, Berger RD, Calkins H, et al. Prospective comparison of the diagnostic utility of a standard event monitor versus a ‘leadless’ portable ECG monitor in the evaluation of patients with palpitations. J Interv Card Electrophysiol. 2008;22:39–44. doi: 10.1007/s10840-008-9251-0.
    1. Zimetbaum PJ, Kim KY, Josephson ME, Goldberger AL, Cohen DJ. Diagnostic yield and optimal duration of continuous-loop event monitoring for the diagnosis of palpitations. Ann Intern Med. 1998;28:890–895. doi: 10.7326/0003-4819-128-11-199806010-00002.
    1. Barrett PM, Komatireddy R, Haaser S, Topol S, Sheard J, Encinas J, et al. Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring. Am J Med. 2014;127:95.e11–95.e17. doi: 10.1016/j.amjmed.2013.10.003.
    1. Cheung CC, Kerr CR, Krahn AD. Comparing 14-day adhesive patch with 24-h Holter monitoring. Future Cardiol. 2014;10(3):319–322. doi: 10.2217/fca.14.24.
    1. AliveCor Heart Monitor and AliveECG app for detecting atrial fibrillation. Medtech innovation briefing. London: National Institute for Health and Care Excellence; 2015. . Accessed 16 Aug 2018.
    1. William AD, Kanbour M, Callahan T, Bhargava M, Varma N, Rickard J, et al. Assessing the accuracy of an automated atrial fibrillation detection algorithm using smartphone technology: The iREAD Study. Heart Rhythm. 2018;15:1561–1565. doi: 10.1016/j.hrthm.2018.06.037.
    1. Summers A, Reed MJ. An evaluation of patient ownership and use and acceptability of smartphone technology within the emergency department. Eur J Emerg Med. 2018;25(3):224–225. doi: 10.1097/MEJ.0000000000000500.
    1. Lau J, Lowres N, Neubeck L, Brieger DB, Sy RW, Galloway CD, et al. iPhone ECG application for community screening to detect silent atrial fibrillation: a novel technology to prevent stroke. Int J Cardiol. 2013;165:193–194. doi: 10.1016/j.ijcard.2013.01.220.
    1. Lowres N, Neubeck L, Salkeld G, Krass I, AJ ML, Redfern J, et al. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCHAF study. Thromb Haemost. 2014;111:1167–1176. doi: 10.1160/TH14-03-0231.
    1. Haberman ZC, Jahn RT, Bose R, Tun H, Shinbane JS, Doshi RN, et al. Wireless smartphone ECG enables large-scale screening in diverse populations. J Cardiovasc Electrophysiol. 2015;26:520–526. doi: 10.1111/jce.12634.
    1. Tarakji KG, Wazni OM, Callahan T, Kanj M, Hakim AH, Wolski K, et al. Using a novel wireless system for monitoring patients after the atrial fibrillation ablation procedure: the iTransmit study. Heart Rhythm. 2015;12:554–559. doi: 10.1016/j.hrthm.2014.11.015.
    1. Desteghe L, Raymaekers Z, Lutin M, Vijgen J, Dilling-Boer D, Koopman P, et al. Performance of handheld electrocardiogram devices to detect atrial fibrillation in a cardiology and geriatric ward setting. Europace. 2017;19:29–39. doi: 10.1093/ehjci/eux151.
    1. Mitchell ARJ, Le Page P. Living with the handheld ECG. BMJ Innovations. 2015;1:46–48. doi: 10.1136/bmjinnov-2014-000029.
    1. Halcox JPJ, Wareham K, Cardew A, Gilmore M, Barry JP, Phillips C, et al. Assessment of remote heart rhythm sampling using the AliveCor heart monitor to screen for atrial fibrillation: the REHEARSE-AF Study. Circulation. 2017;136:1784–1794. doi: 10.1161/CIRCULATIONAHA.117.030583.
    1. (Accessed 17 Sept 2018).

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit